Global (United States, European Union and China) Transthyretin Market Research Report 2019-2025
1 Study Coverage
- 1.1 Transthyretin Product Introduction
- 1.2 Market Segments
- 1.3 Key Transthyretin Manufacturers Covered: Ranking by Revenue
- 1.4 Market by Type
- 1.4.1 Global Transthyretin Market Size Growth Rate by Type
- 1.4.2 AG-10
- 1.4.3 ALN-TTRsc02
- 1.4.4 CRX-1008
- 1.4.5 EDE-1307
- 1.4.6 Inotersen Sodium
- 1.4.7 Others
- 1.5 Market by Application
- 1.5.1 Global Transthyretin Market Size Growth Rate by Application
- 1.5.2 Familial Amyloid Neuropathies
- 1.5.3 Alzheimer's Disease
- 1.5.4 Cardomyopathy
- 1.5.5 Neuropathy
- 1.5.6 Others
- 1.6 Study Objectives
- 1.7 Years Considered
2 Executive Summary
- 2.1 Global Transthyretin Market Size, Estimates and Forecasts
- 2.1.1 Global Transthyretin Revenue 2015-2026
- 2.1.2 Global Transthyretin Sales 2015-2026
- 2.2 Global Transthyretin, Market Size by Producing Regions: 2015 VS 2020 VS 2026
- 2.2.1 Global Transthyretin Retrospective Market Scenario in Sales by Region: 2015-2020
- 2.2.2 Global Transthyretin Retrospective Market Scenario in Revenue by Region: 2015-2020
3 Global Transthyretin Competitor Landscape by Players
- 3.1 Transthyretin Sales by Manufacturers
- 3.1.1 Transthyretin Sales by Manufacturers (2015-2020)
- 3.1.2 Transthyretin Sales Market Share by Manufacturers (2015-2020)
- 3.2 Transthyretin Revenue by Manufacturers
- 3.2.1 Transthyretin Revenue by Manufacturers (2015-2020)
- 3.2.2 Transthyretin Revenue Share by Manufacturers (2015-2020)
- 3.2.3 Global Transthyretin Market Concentration Ratio (CR5 and HHI) (2015-2020)
- 3.2.4 Global Top 10 and Top 5 Companies by Transthyretin Revenue in 2019
- 3.2.5 Global Transthyretin Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
- 3.3 Transthyretin Price by Manufacturers
- 3.4 Transthyretin Manufacturing Base Distribution, Product Types
- 3.4.1 Transthyretin Manufacturers Manufacturing Base Distribution, Headquarters
- 3.4.2 Manufacturers Transthyretin Product Type
- 3.4.3 Date of International Manufacturers Enter into Transthyretin Market
- 3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
- 4.1 Global Transthyretin Market Size by Type (2015-2020)
- 4.1.1 Global Transthyretin Sales by Type (2015-2020)
- 4.1.2 Global Transthyretin Revenue by Type (2015-2020)
- 4.1.3 Transthyretin Average Selling Price (ASP) by Type (2015-2026)
- 4.2 Global Transthyretin Market Size Forecast by Type (2021-2026)
- 4.2.1 Global Transthyretin Sales Forecast by Type (2021-2026)
- 4.2.2 Global Transthyretin Revenue Forecast by Type (2021-2026)
- 4.2.3 Transthyretin Average Selling Price (ASP) Forecast by Type (2021-2026)
- 4.3 Global Transthyretin Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Market Size by Application (2015-2026)
- 5.1 Global Transthyretin Market Size by Application (2015-2020)
- 5.1.1 Global Transthyretin Sales by Application (2015-2020)
- 5.1.2 Global Transthyretin Revenue by Application (2015-2020)
- 5.1.3 Transthyretin Price by Application (2015-2020)
- 5.2 Transthyretin Market Size Forecast by Application (2021-2026)
- 5.2.1 Global Transthyretin Sales Forecast by Application (2021-2026)
- 5.2.2 Global Transthyretin Revenue Forecast by Application (2021-2026)
- 5.2.3 Global Transthyretin Price Forecast by Application (2021-2026)
6 North America
- 6.1 North America Transthyretin by Country
- 6.1.1 North America Transthyretin Sales by Country
- 6.1.2 North America Transthyretin Revenue by Country
- 6.1.3 U.S.
- 6.1.4 Canada
- 6.2 North America Transthyretin Market Facts & Figures by Type
- 6.3 North America Transthyretin Market Facts & Figures by Application
7 Europe
- 7.1 Europe Transthyretin by Country
- 7.1.1 Europe Transthyretin Sales by Country
- 7.1.2 Europe Transthyretin Revenue by Country
- 7.1.3 Germany
- 7.1.4 France
- 7.1.5 U.K.
- 7.1.6 Italy
- 7.1.7 Russia
- 7.2 Europe Transthyretin Market Facts & Figures by Type
- 7.3 Europe Transthyretin Market Facts & Figures by Application
8 Asia Pacific
- 8.1 Asia Pacific Transthyretin by Region
- 8.1.1 Asia Pacific Transthyretin Sales by Region
- 8.1.2 Asia Pacific Transthyretin Revenue by Region
- 8.1.3 China
- 8.1.4 Japan
- 8.1.5 South Korea
- 8.1.6 India
- 8.1.7 Australia
- 8.1.8 Taiwan
- 8.1.9 Indonesia
- 8.1.10 Thailand
- 8.1.11 Malaysia
- 8.1.12 Philippines
- 8.1.13 Vietnam
- 8.2 Asia Pacific Transthyretin Market Facts & Figures by Type
- 8.3 Asia Pacific Transthyretin Market Facts & Figures by Application
9 Latin America
- 9.1 Latin America Transthyretin by Country
- 9.1.1 Latin America Transthyretin Sales by Country
- 9.1.2 Latin America Transthyretin Revenue by Country
- 9.1.3 Mexico
- 9.1.4 Brazil
- 9.1.5 Argentina
- 9.2 Central & South America Transthyretin Market Facts & Figures by Type
- 9.3 Central & South America Transthyretin Market Facts & Figures by Application
10 Middle East and Africa
- 10.1 Middle East and Africa Transthyretin by Country
- 10.1.1 Middle East and Africa Transthyretin Sales by Country
- 10.1.2 Middle East and Africa Transthyretin Revenue by Country
- 10.1.3 Turkey
- 10.1.4 Saudi Arabia
- 10.1.5 U.A.E
- 10.2 Middle East and Africa Transthyretin Market Facts & Figures by Type
- 10.3 Middle East and Africa Transthyretin Market Facts & Figures by Application
11 Company Profiles
- 11.1 Alnylam Pharmaceuticals Inc
- 11.1.1 Alnylam Pharmaceuticals Inc Corporation Information
- 11.1.2 Alnylam Pharmaceuticals Inc Description and Business Overview
- 11.1.3 Alnylam Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Alnylam Pharmaceuticals Inc Transthyretin Products Offered
- 11.1.5 Alnylam Pharmaceuticals Inc Related Developments
- 11.2 Arcturus Therapeutics Inc
- 11.2.1 Arcturus Therapeutics Inc Corporation Information
- 11.2.2 Arcturus Therapeutics Inc Description and Business Overview
- 11.2.3 Arcturus Therapeutics Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.2.4 Arcturus Therapeutics Inc Transthyretin Products Offered
- 11.2.5 Arcturus Therapeutics Inc Related Developments
- 11.3 Ionis Pharmaceuticals Inc
- 11.3.1 Ionis Pharmaceuticals Inc Corporation Information
- 11.3.2 Ionis Pharmaceuticals Inc Description and Business Overview
- 11.3.3 Ionis Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.3.4 Ionis Pharmaceuticals Inc Transthyretin Products Offered
- 11.3.5 Ionis Pharmaceuticals Inc Related Developments
- 11.4 Neurimmune Holding AG
- 11.4.1 Neurimmune Holding AG Corporation Information
- 11.4.2 Neurimmune Holding AG Description and Business Overview
- 11.4.3 Neurimmune Holding AG Sales, Revenue and Gross Margin (2015-2020)
- 11.4.4 Neurimmune Holding AG Transthyretin Products Offered
- 11.4.5 Neurimmune Holding AG Related Developments
- 11.5 Pfizer Inc
- 11.5.1 Pfizer Inc Corporation Information
- 11.5.2 Pfizer Inc Description and Business Overview
- 11.5.3 Pfizer Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.5.4 Pfizer Inc Transthyretin Products Offered
- 11.5.5 Pfizer Inc Related Developments
- 11.6 Prothena Corp Plc
- 11.6.1 Prothena Corp Plc Corporation Information
- 11.6.2 Prothena Corp Plc Description and Business Overview
- 11.6.3 Prothena Corp Plc Sales, Revenue and Gross Margin (2015-2020)
- 11.6.4 Prothena Corp Plc Transthyretin Products Offered
- 11.6.5 Prothena Corp Plc Related Developments
- 11.7 Regeneron Pharmaceuticals Inc
- 11.7.1 Regeneron Pharmaceuticals Inc Corporation Information
- 11.7.2 Regeneron Pharmaceuticals Inc Description and Business Overview
- 11.7.3 Regeneron Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.7.4 Regeneron Pharmaceuticals Inc Transthyretin Products Offered
- 11.7.5 Regeneron Pharmaceuticals Inc Related Developments
- 11.1 Alnylam Pharmaceuticals Inc
- 11.1.1 Alnylam Pharmaceuticals Inc Corporation Information
- 11.1.2 Alnylam Pharmaceuticals Inc Description and Business Overview
- 11.1.3 Alnylam Pharmaceuticals Inc Sales, Revenue and Gross Margin (2015-2020)
- 11.1.4 Alnylam Pharmaceuticals Inc Transthyretin Products Offered
- 11.1.5 Alnylam Pharmaceuticals Inc Related Developments
12 Future Forecast by Regions (Countries) (2021-2026)
- 12.1 Transthyretin Market Estimates and Projections by Region
- 12.1.1 Global Transthyretin Sales Forecast by Regions 2021-2026
- 12.1.2 Global Transthyretin Revenue Forecast by Regions 2021-2026
- 12.2 North America Transthyretin Market Size Forecast (2021-2026)
- 12.2.1 North America: Transthyretin Sales Forecast (2021-2026)
- 12.2.2 North America: Transthyretin Revenue Forecast (2021-2026)
- 12.2.3 North America: Transthyretin Market Size Forecast by Country (2021-2026)
- 12.3 Europe Transthyretin Market Size Forecast (2021-2026)
- 12.3.1 Europe: Transthyretin Sales Forecast (2021-2026)
- 12.3.2 Europe: Transthyretin Revenue Forecast (2021-2026)
- 12.3.3 Europe: Transthyretin Market Size Forecast by Country (2021-2026)
- 12.4 Asia Pacific Transthyretin Market Size Forecast (2021-2026)
- 12.4.1 Asia Pacific: Transthyretin Sales Forecast (2021-2026)
- 12.4.2 Asia Pacific: Transthyretin Revenue Forecast (2021-2026)
- 12.4.3 Asia Pacific: Transthyretin Market Size Forecast by Region (2021-2026)
- 12.5 Latin America Transthyretin Market Size Forecast (2021-2026)
- 12.5.1 Latin America: Transthyretin Sales Forecast (2021-2026)
- 12.5.2 Latin America: Transthyretin Revenue Forecast (2021-2026)
- 12.5.3 Latin America: Transthyretin Market Size Forecast by Country (2021-2026)
- 12.6 Middle East and Africa Transthyretin Market Size Forecast (2021-2026)
- 12.6.1 Middle East and Africa: Transthyretin Sales Forecast (2021-2026)
- 12.6.2 Middle East and Africa: Transthyretin Revenue Forecast (2021-2026)
- 12.6.3 Middle East and Africa: Transthyretin Market Size Forecast by Country (2021-2026)
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
- 13.1 Market Opportunities and Drivers
- 13.2 Market Challenges
- 13.3 Market Risks/Restraints
- 13.4 Porter's Five Forces Analysis
- 13.5 Primary Interviews with Key Transthyretin Players (Opinion Leaders)
14 Value Chain and Sales Channels Analysis
- 14.1 Value Chain Analysis
- 14.2 Transthyretin Customers
- 14.3 Sales Channels Analysis
- 14.3.1 Sales Channels
- 14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
- 16.1 Research Methodology
- 16.1.1 Methodology/Research Approach
- 16.1.2 Data Source
- 16.2 Author Details
Transthyretin market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Transthyretin market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by Type and by Application for the period 2015-2026.
Segment by Type, the Transthyretin market is segmented into
AG-10
ALN-TTRsc02
CRX-1008
EDE-1307
Inotersen Sodium
Others
Segment by Application, the Transthyretin market is segmented into
Familial Amyloid Neuropathies
Alzheimer's Disease
Cardomyopathy
Neuropathy
Others
Regional and Country-level Analysis
The Transthyretin market is analysed and market size information is provided by regions (countries).
The key regions covered in the Transthyretin market report are North America, Europe, Asia Pacific, Latin America, Middle East and Africa. It also covers key regions (countries), viz, U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E, etc.
The report includes country-wise and region-wise market size for the period 2015-2026. It also includes market size and forecast by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Transthyretin Market Share Analysis
Transthyretin market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Transthyretin business, the date to enter into the Transthyretin market, Transthyretin product introduction, recent developments, etc.
The major vendors covered:
Alnylam Pharmaceuticals Inc
Arcturus Therapeutics Inc
Ionis Pharmaceuticals Inc
Neurimmune Holding AG
Pfizer Inc
Prothena Corp Plc
Regeneron Pharmaceuticals Inc
...